Although it was thought that apoptotic cells, when rapidly phagocytosed, underwent a silent
death that did not trigger an immune response, in recent years a new concept of …

Multicentric Castleman's disease (MCD) describes a heterogeneous group of disorders
involving proliferation of morphologically benign lymphocytes due to excessive …

Disease overview Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell
lymphoproliferative disorders involving the skin, the majority of which may be classified as …

Castleman disease (CD) describes a heterogeneous group of hematologic disorders that
share characteristic lymph node histopathology. Patients of all ages present with either a …

Disease overview: Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell
lymphoproliferative disorders involving the skin, the majority of which may be classified as …

Cutaneous T‐cell lymphomas (CTCL) are a heterogeneous group of malignancies derived
from skin‐homing T cells. The most common forms of CTCL are Mycosis Fungoides (MF) …

Both apoptosis and autophagy are highly conserved processes that besides their role in the
maintenance of the organismal and cellular homeostasis serve as a main target of tumor …

Due to its potent anticancer activity, there is interest in repurposing of the FDA-approved anti-
alcoholism drug, disulfiram (DSF). DSF forms potent complexes with copper (DSF/Cu) that …

Multiple myeloma (MM) is a hematological malignancy characterized by the aberrant
accumulation of clonal plasma cells in the bone marrow. Despite recent advancement in anti …

Bone marrow microenvironment is known to support angiogenesis, thus contributing to
progression of multiple myeloma (MM). Bortezomib, a proteasome inhibitor (PI) widely used …